Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process … – Nasdaq
|
Cesca Therapeutics' Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR–T Manufacturing Process …
Nasdaq Cesca Therapeutics Inc. (the "Company") develops, commercializes and markets a range of automated technologies for CAR–T and other cell-based therapies. Its device division, ThermoGenesis Corp., provides a full suite of solutions for automated clinical … |
